Navigation Links
Global Markets and Technologies for Optical Coherence Tomography (OCT)
Date:5/21/2013

NEW YORK, May 21, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

Global Markets and Technologies for Optical Coherence Tomography (OCT)

http://www.reportlinker.com/p01187977/Global-Markets-and-Technologies-for-Optical-Coherence-Tomography-OCT.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging

 

STUDY OBJECTIVES

 

BCC's aim in conducting this study is to offer synopsis of the current and future characteristics of the global market for optical coherence tomography (OCT). The key objective is to present a comprehensive analysis and future trend and research of OCT as an important tool for the usage of this technique in imaging.

 

This report explores present and future different OCT techniques and their usage and developments within the OCT market. This report includes different types of OCT techniques such as time domain and large-field high-speed polarization sensitive system, Fourier domain or spectral domain and time-encoded frequency domain or swept source, full-field optical coherence and optical delay scanning. The improvisation of the market, the setbacks and the needs of the market are discussed in this report. The classification, new developments and usage of these types of techniques are also portrayed in this report.

 

A detailed analysis of the OCT industry has been conducted. Revenues are broken down by region. Sales figures are estimated for the five-year period from 2012 through 2017.

Applications for OCT are also discussed in this report, with an emphasis of the usage of this technique in different therapeutic categories and various other industries. This report also covers significant patents and their allotments in each category.

 

Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of each type/ technology in light of the new technologies, growing competition and changing customer needs.

 

REASONS FOR DOING THIS STUDY

 

Extensive research in the OCT field has revealed its current usage in various applications and its usage in the future. The report also covers current research and developments going on in this field. This report also discusses the usage of OCT techniques over other current imaging techniques such as magnetic resonance imaging and ultrasound imaging. Researchers are exploring the advantages of OCT in newer areas, leading to the increased usage and consumption of these techniques. R&D spending, patents and research in this field are giving a new direction. The advancements, new product launches and the early disease detection awareness influenced the market to grow in the foreseeable future. This study looks at almost all of the systems affected by these factors.

 

CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE

 

This study contributes to the areas of market growth in OCT manufacturers and users. Pharmaceutical, biotechnical companies, research institutes and analytical/diagnostic institutes will find this study to be of interest.

 

SCOPE OF THE STUDY

 

The scope of this study embraces OCT in medical and other markets. BCC analyzed each market and its applications, regulatory environment, technology, market projections and market shares. Technological issues include the latest trends and developments. The emerging markets for OCT include countries such as India, China, Japan, Korea, Taiwan, Africa, Australia, New Zealand, etc.

 

METHODOLOGY

 

Both primary and secondary research methodologies were used in preparing this study. BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with manufacturers of OCT technical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions and market trends.

 

INFORMATION SOURCES

 

Many companies were surveyed to obtain data for this study, including manufacturers and end users of OCT. Data were gathered from various industry sources. BCC spoke with officials within the industry and consulted newsletters, company literature, product literature and a host of technical articles, journals, indexes and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade and government sources.

 

ABOUT THE AUTHOR

 

A team of professionals in the biotechnology industry carried out this study. The project manager was Shalini S. Dewan , who holds a Master's degree in pharmaceutical chemistry and has over 14 years of industry experience. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC are: Reagents for Chromatography; Spectroscopy: An Enduring Market; Advanced Drug Delivery Systems: Technologies and Global Markets; Orthopedic Drugs, Implants and Devices; Medical Imaging Reagents and Analysis Equipment; Pharmaceutical Regulatory Industry; The Dynamic Media, Sera and Reagent Market in Biotechnology; Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets; Chiral Technology: Global Markets; Autacoids and Related Drugs: Technologies and Global Markets; Contraceptives: Technologies and Global Markets; Liver Disease Treatments: The Global Market; Hormone Replacement Therapies and Other Hormone Therapies: Global Markets; Cardiovascular Medicine: Diagnostics, Drugs and Devices; and Cancer Therapies: Technologies and Global Markets.

 

REPORT HIGHLIGHTS

 

This report provides:

 

• An overview of the global market for optical coherence tomography (OCT), including details on system technology segments: traditional (time domain), frequency domain, and other modes of OCT measurement.

• Analyses of global market trends, with data from 2010 to 2012, and projections of compound annual growth rates (CAGRs) through 2017.

• A breakdown of OCT formats, including office/tabletop, catheter-based, and handheld.

• Regulatory status of the devices in the U.S., EU, and other regions.

• Delineation of the major markets for the technology, including ophthalmology, cardiovascular, oncology, dermatology, and dental applications.

• Comprehensive company profiles of major players.

 

 

 

TABLE OF CONTENTS

 

CHAPTER 1 INTRODUCTION 2

 

STUDY OBJECTIVES 2

REASONS FOR DOING THIS STUDY 2

CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE 3

SCOPE OF THE STUDY 3

METHODOLOGY 3

INFORMATION SOURCES 3

ABOUT THE AUTHOR 3

RELATED BCC RESEARCH REPORTS 4

BCC ONLINE SERVICES 4

DISCLAIMER 4

 

CHAPTER 2 SUMMARY 6

 

SUMMARY TABLE GLOBAL REVENUE OF OCT MARKET, THROUGH 2017 ($ MILLIONS) 8

SUMMARY FIGURE GLOBAL REVENUE OF OCT MARKET, 2010-2017 ($ MILLIONS) 8

 

CHAPTER 3 OVERVIEW 10

 

TABLE 1 MAIN CHARACTERISTICS OF OCT 10

USES OF OPTICAL COHERENCE TOMOGRAPHY 11

TABLE 2 USES OF OPTICAL COHERENCE TOMOGRAPHY 11

ADVANTAGES AND DISADVANTAGES OF OPTICAL COHERENCE TOMOGRAPHY 11

TABLE 3 ADVANTAGES AND DISADVANTAGES OF OPTICAL COHERENCE

TOMOGRAPHY 12

APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY 12

TABLE 4 APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY 13

HISTORY OF OPTICAL COHERENCE TOMOGRAPHY 13

TABLE 5 HISTORICAL DEVELOPMENTS IN OPTICAL COHERENCE TOMOGRAPHY 14

CLASSIFICATION 14

TABLE 6 TYPE OF TECHNOLOGIES USED IN OPTICAL COHERENCE TOMOGRAPHY 15

TABLE 7 MODES OF IMPLEMENTATION IN OPTICAL COHERENCE TOMOGRAPHY 15

TYPES OF TECHNOLOGY 15

TRADITIONAL (TIME DOMAIN) OCT 15

POLARIZATION SENSITIVE (PS)-OCT 16

FREQUENCY DOMAIN OCT 16

Fourier or Spectral Domain OCT 17

Time-Encoded Frequency Domain OCT 17

OTHERS 18

Full-Field Optical Coherence 18

Optical Delay Scanning 18

TABLE 8 COMPARISON OF DIFFERENT OCT TECHNOLOGY 19

MODE OF IMPLEMENTATION 19

OFFICE/TABLETOP OCT 19

CATHETER-BASED OCT 20

HANDHELD OCT DEVICES 20

OCT SPECTROMETERS 21

DOPPLER OPTICAL COHERENCE TOMOGRAPHY (OCT) SYSTEM 21

 

CHAPTER 4 REGULATORY ASPECTS 23

 

NEW PRODUCTS APPROVED FROM 2008 TO 2012 24

TABLE 9 NEW OCT PRODUCTS APPROVED FROM 2008 TO 2012 24

RECALLS AND SAFETY ALERTS 27

TABLE 10 RECALLS AND SAFETY ALERTS FROM 2008 TO 2012 28

 

CHAPTER 5 NEW DEVELOPMENTS 30

 

NEW PARTNERSHIPS, MERGERS AND ACQUISITION 31

NEW PRODUCTS 32

TABLE 11 NEW OCT INNOVATIONS FROM 2008 TO 2012 33

PIPELINE PRODUCTS 34

TABLE 12 PIPELINE PRODUCTS FOR THE OCT MARKET 36

 

CHAPTER 6 GLOBAL MARKETS FOR OPTICAL COHERENCE TOMOGRAPHY 38

 

MARKET BY TYPE 39

MARKET OVERVIEW 39

MARKET REVENUE 41

TABLE 13 GLOBAL REVENUE OF OCT BY TYPE, THROUGH 2017 ($ MILLIONS) 41

FIGURE 1 GLOBAL REVENUE OF OCT BY TYPE, 2010-2017 ($ MILLIONS) 41

MARKET SHARE 42

TABLE 14 MARKET SHARES OF OCT BY TYPE, 2011 (%) 42

FIGURE 2 MARKET SHARES OF OCT BY TYPE, 2011 (%) 42

MARKET BY REGION 42

MARKET OVERVIEW 43

MARKET REVENUE 45

TABLE 15 GLOBAL REVENUE OF OCT BY REGION, THROUGH 2017 ($ MILLIONS) 45

FIGURE 3 GLOBAL REVENUE OF OCT BY REGION, 2010-2017 ($ MILLIONS) 45

MARKET SHARE 46

TABLE 16 GLOBAL MARKET SHARE OF OCT BY REGION, 2011 (%) 46

FIGURE 4 GLOBAL MARKET SHARE OF OCT BY REGION, 2011 (%) 46

MARKET FOR TIME DOMAIN OCT AND POLARIZATION SENSITIVE OCT 47

TABLE 17 GLOBAL REVENUE OF TD-OCT AND PS-OCT BY REGION, THROUGH 2017

($ MILLIONS) 47

FIGURE 5 GLOBAL REVENUE OF TD-OCT AND PS-OCT BY REGION, 2010-2017 ($

MILLIONS) 47

MARKET SHARE 48

TABLE 18 MARKET SHARE OF GLOBAL REVENUE OF TD-OCT AND PS-OCT BY

REGION, 2011 (%) 48

FIGURE 6 MARKET SHARE OF GLOBAL REVENUE OF TD-OCT AND PS-OCT BY

REGION, 2011 (%) 48

MARKET FOR FOURIER DOMAIN AND TIME-ENCODED OCT 49

TABLE 19 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT BY REGION,

THROUGH 2017 ($ MILLIONS) 49

FIGURE 7 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT BY REGION,

2010-2017 ($ MILLIONS) 49

MARKET SHARE 50

TABLE 20 MARKET SHARE OF FD-OCT AND TIME-ENCODED OCT BY REGION, 2011

(%) 50

FIGURE 8 MARKET SHARE OF FD-OCT AND TIME-ENCODED OCT BY REGION, 2011

(%) 50

MARKET FOR FULL-FIELD AND OPTICAL DELAY OPTICAL COHERENCE OCT 51

TABLE 21 GLOBAL REVENUE OF FF-OCT AND OD-OCT BY REGION, THROUGH 2017

($ MILLIONS) 51

FIGURE 9 GLOBAL REVENUE OF FF-OCT AND OD-OCT BY REGION, 2010-2017 ($

MILLIONS) 51

MARKET SHARE 52

TABLE 22 MARKET SHARE OF FF-OCT AND OD-OCT BY REGION, 2011 (%) 52

FIGURE 10 MARKET SHARE OF FF-OCT AND OD-OCT BY REGION, 2011 (%) 52

MARKET BY END USERS 53

MARKET OVERVIEW 54

MARKET REVENUE 59

TABLE 23 GLOBAL MARKET OF OCT BY END USERS, THROUGH 2017 ($ MILLIONS) 60

FIGURE 11 GLOBAL MARKET OF OCT BY END USERS, 2010-2017 ($ MILLIONS) 60

MARKET SHARE 61

TABLE 24 GLOBAL MARKET SHARE OF OCT BY END USERS, 2011 (%) 61

FIGURE 12 GLOBAL MARKET SHARE OF OCT BY END USERS, 2011 (%) 61

 

CHAPTER 7 MARKET ANALYSIS OF TIME DOMAIN AND POLARIZATION SENSITIVE

 

OPTICAL COHERENCE TOMOGRAPHY 63

MARKET BY TYPE 63

MARKET OVERVIEW 63

MARKET REVENUE 64

TABLE 25 GLOBAL REVENUE OF TD-OCT AND PS-OCT, THROUGH 2017 ($ MILLIONS) 64

FIGURE 13 GLOBAL REVENUE OF TD-OCT AND PS-OCT, 2010-2017 ($ MILLIONS) 64

MARKET SHARE 65

TABLE 26 MARKET SHARE OF TD-OCT AND PS-OCT BY TYPE, 2011 (%) 65

FIGURE 14 MARKET SHARE OF TD-OCT AND PS-OCT BY TYPE, 2011 (%) 65

MARKET BY REGION 66

MARKET OVERVIEW 66

MARKET REVENUE 67

Time Domain OCT 67

TABLE 27 GLOBAL REVENUE OF TD-OCT BY REGION, THROUGH 2017 ($ MILLIONS) 68

FIGURE 15 GLOBAL REVENUE OF TD-OCT BY REGION, 2010-2017 ($ MILLIONS) 68

Polarization Sensitive OCT 68

TABLE 28 GLOBAL REVENUE OF PS-OCT BY REGION, THROUGH 2017 ($ MILLIONS) 68

FIGURE 16 GLOBAL REVENUE OF PS-OCT BY REGION, 2010-2017 ($ MILLIONS) 69

MARKET SHARE 69

TABLE 29 MARKET SHARE OF PS-OCT BY REGION, 2011 (%) 70

FIGURE 17 MARKET SHARE OF PS-OCT BY REGION, 2011 (%) 70

MARKETS BY END USERS 70

TABLE 30 GLOBAL REVENUE OF PS-OCT AND TD-OCT BY END USERS, THROUGH

2017 ($ MILLIONS) 70

FIGURE 18 GLOBAL REVENUE OF PS-OCT AND TD-OCT BY END USERS, 2010-2017

($ MILLIONS) 72

PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY 72

Market Revenue 73

TABLE 31 GLOBAL EXPENDITURE OF TD-OCT AND PS-OCT IN THE

PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES, THROUGH 2017 ($

MILLIONS)

73

FIGURE 19 GLOBAL EXPENDITURE OF TD-OCT AND PS-OCT IN THE

PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES, 2010-2017 ($ MILLIONS) 73

ENVIRONMENTAL SCIENCE INDUSTRY 74

Market Revenue 74

TABLE 32 GLOBAL EXPENDITURE OF TD-OCT AND PS-OCT IN THE ENVIRONMENTAL

SCIENCES INDUSTRY, THROUGH 2017 ($ MILLIONS) 75

FIGURE 20 GLOBAL EXPENDITURE OF TD-OCT AND PS-OCT IN THE

ENVIRONMENTAL SCIENCES INDUSTRY, 2010-2017 ($ MILLIONS) 75

FOOD AND BEVERAGE INDUSTRY 76

Market Revenue 76

TABLE 33 GLOBAL EXPENDITURE OF TD-OCT AND PS-OCT IN THE FOOD AND

BEVERAGE INDUSTRY, THROUGH 2017 ($ MILLIONS) 76

FIGURE 21 GLOBAL EXPENDITURE OF TD-OCT AND PS-OCT IN THE FOOD AND

BEVERAGE INDUSTRY, 2010-2017 ($ MILLIONS) 77

OTHER INDUSTRIES 77

Market Revenue 77

TABLE 34 GLOBAL EXPENDITURE OF TD-OCT AND PS-OCT IN OTHER INDUSTRIES,

THROUGH 2017 ($ MILLIONS) 78

FIGURE 22 GLOBAL EXPENDITURE OF TD-OCT AND PS-OCT IN OTHER INDUSTRIES,

2010-2017 ($ MILLIONS) 78

MARKET SHARE 78

TABLE 35 MARKET SHARE OF TD-OCT AND PS-OCT BY APPLICATION, 2011 (%) 79

FIGURE 23 MARKET SHARE OF TD-OCT AND PS-OCT BY APPLICATION, 2011 (%) 79

INDUSTRY STRUCTURE 79

TIME DOMAIN OPTICAL COHERENCE TOMOGRAPHY 79

Market Leaders 79

TABLE 36 MAJOR MANUFACTURERS IN TD-OCT, 2011 80

Market Share 80

TABLE 37 MARKET SHARE FOR MANUFACTURERS IN TD-OCT, 2011 (%) 80

FIGURE 24 MARKET SHARE FOR MANUFACTURERS IN TD-OCT, 2011 (%) 80

POLARIZATION SENSITIVE OPTICAL COHERENCE TOMOGRAPHY 81

Market Leaders 81

TABLE 38 MAJOR MANUFACTURERS IN PS-OCT, 2011 81

Market Share 81

TABLE 39 MARKET SHARE FOR THE MANUFACTURERS IN PS-OCT, 2011 (%) 81

FIGURE 25 MARKET SHARE FOR THE MANUFACTURERS IN PS-OCT, 2011 (%) 81

 

CHAPTER 8 MARKET ANALYSIS FOR FOURIER DOMAIN AND TIME-ENCODED OCT 84

 

MARKET BY TYPE 84

MARKET OVERVIEW 85

MARKET REVENUE 85

TABLE 40 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT BY TYPE,

THROUGH 2017 ($ MILLIONS) 86

FIGURE 26 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT BY TYPE,

2010-2017 ($ MILLIONS) 86

MARKET SHARE 86

TABLE 41 MARKET SHARE OF FD-OCT AND TIME-ENCODED OCT, 2011 (%) 87

FIGURE 27 MARKET SHARE OF FD-OCT AND TIME-ENCODED OCT, 2011 (%) 87

MARKET BY REGION 87

MARKET OVERVIEW 87

MARKET REVENUE 88

TABLE 42 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT BY REGION,

THROUGH 2017 ($ MILLIONS) 89

FIGURE 28 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT BY REGION,

2010-2017 ($ MILLIONS) 89

FOURIER DOMAIN OCT 89

TABLE 43 GLOBAL REVENUE OF FD-OCT BY REGION, THROUGH 2017 ($ MILLIONS) 90

FIGURE 29 GLOBAL REVENUE OF FD-OCT BY REGION, 2010-2017 ($ MILLIONS) 90

TIME-ENCODED OCT 90

TABLE 44 GLOBAL REVENUE OF TIME-ENCODED OCT BY REGION, THROUGH 2017

($ MILLIONS) 91

FIGURE 30 GLOBAL REVENUE OF TIME-ENCODED OCT BY REGION, 2010-2017 ($

MILLIONS) 91

MARKET SHARE 92

TABLE 45 MARKET SHARES OF FD-OCT AND TIME-ENCODED OCT BY REGION, 2011

(%) 92

FIGURE 31 MARKET SHARES OF FD-OCT AND TIME-ENCODED OCT BY REGION,

2011 (%) 92

BY END USER 92

TABLE 46 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT BY END USERS,

THROUGH 2017 ($ MILLIONS) 93

FIGURE 32 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT BY END USERS,

2010-2017 ($ MILLIONS) 93

CARDIOLOGY 94

Market Revenue 94

TABLE 47 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED DOMAIN OCT IN

CARDIOLOGY, THROUGH 2017 ($ MILLIONS) 95

FIGURE 33 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED DOMAIN OCT IN

CARDIOLOGY, 2010-2017 ($ MILLIONS) 95

OPHTHALMOLOGY 96

Market Revenue 97

TABLE 48 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT IN

OPHTHALMOLOGY, THROUGH 2017 ($ MILLIONS) 97

FIGURE 34 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT IN

OPHTHALMOLOGY, 2010-2017 ($ MILLIONS) 97

ONCOLOGY 98

Market Revenue 98

TABLE 49 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT IN ONCOLOGY,

THROUGH 2017 ($ MILLIONS) 98

FIGURE 35 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT IN ONCOLOGY,

2010-2017 ($ MILLIONS) 99

OTHERS 99

Market Revenue 100

TABLE 50 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT IN OTHER

SECTORS, THROUGH 2017 ($ MILLIONS) 100

FIGURE 36 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT IN OTHER

SECTORS, 2010-2017 ($ MILLIONS) 101

MARKET SHARE 101

TABLE 51 MARKET SHARE OF FD-OCT AND TIME-ENCODED OCT, 2011 (%) 101

FIGURE 37 MARKET SHARE OF FD-OCT AND TIME-ENCODED OCT, 2011 (%) 101

INDUSTRY STRUCTURE 102

FOURIER DOMAIN OCT 102

Market Leaders 102

TABLE 52 MAJOR MANUFACTURERS IN FOURIER OR SPECTRAL DOMAIN OCT, 2011 102

Market Shares 103

TABLE 53 MARKET SHARE OF THE MANUFACTURERS IN FOURIER OR SPECTRAL

DOMAIN OCT, 2011 (%) 103

FIGURE 38 MARKET SHARE OF THE MANUFACTURERS IN FOURIER OR SPECTRAL

DOMAIN OCT, 2011 (%) 103

TIME-ENCODED OCT 104

Market Leaders 104

TABLE 54 MAJOR MANUFACTURERS IN TIME-ENCODED OCT OR SS-OCT, 2011 104

Market Shares 104

TABLE 55 MARKET SHARE OF THE MANUFACTURERS OF TIME-ENCODED OCT OR

SS-OCT, 2011 (%) 104

FIGURE 39 MARKET SHARE OF THE MANUFACTURERS OF TIME-ENCODED OCT OR

SS-OCT, 2011 (%) 104

 

CHAPTER 9 MARKETS ANALYSIS FOR FULL-FIELD AND OPTICAL DELAY OPTICAL COHERENCE TOMOGRAPHY 107

 

MARKET BY TYPE 108

MARKET OVERVIEW 108

MARKET REVENUE 109

TABLE 56 GLOBAL REVENUE OF FF-OCT AND OD-OCT, THROUGH 2017 ($ MILLIONS) 109

FIGURE 40 GLOBAL REVENUE OF FF-OCT AND OD-OCT, 2010–2017 ($ MILLIONS) 109

MARKET SHARE 110

TABLE 57 MARKET SHARE OF FF-OCT AND OD-OCT BY TYPE, 2011 (%) 110

FIGURE 41 MARKET SHARE OF FF-OCT AND OD-OCT BY TYPE, 2011 (%) 110

MARKETS BY REGIONS 111

MARKET OVERVIEW 111

MARKET REVENUE 112

TABLE 58 GLOBAL REVENUE OF FF-OCT AND OD-OCT BY REGION, THROUGH 2017

($ MILLIONS) 112

FIGURE 42 GLOBAL REVENUE OF FF-OCT AND OD-OCT BY REGION, 2010-2017 ($

MILLIONS) 113

FULL-FIELD OPTICAL COHERENCE OCT 113

TABLE 59 GLOBAL REVENUE OF FF-OCT BY REGION, THROUGH 2017 ($ MILLIONS) 113

FIGURE 43 GLOBAL REVENUE OF FF-OCT BY REGION, THROUGH 2017 ($ MILLIONS) 114

OPTICAL DELAY OCT 114

TABLE 60 GLOBAL REVENUE OF OD-OCT BY REGION, THROUGH 2017 ($ MILLIONS) 114

FIGURE 44 GLOBAL REVENUE OF OD-OCT BY REGION, 2010-2017 ($ MILLIONS) 114

MARKET SHARE 115

TABLE 61 MARKET SHARE OF FF-OCT AND OD-OCT BY REGION, 2011 (%) 115

FIGURE 45 MARKET SHARE OF FF-OCT AND OD-OCT BY REGION, 2011 (%) 115

MARKETS BY END USERS 116

TABLE 62 GLOBAL REVENUE OF FF-OCT AND OD-OCT BY END USERS, THROUGH

2017 ($ MILLIONS) 117

FIGURE 46 GLOBAL REVENUE OF FF-OCT AND OD-OCT BY END USERS, 2010-2017

($ MILLIONS) 117

ENDOSCOPY 118

Market Revenue 118

TABLE 63 GLOBAL REVENUE OF FF-OCT AND OD-OCT IN ENDOSCOPY, THROUGH

2017 ($ MILLIONS) 119

FIGURE 47 GLOBAL REVENUE OF FF-OCT AND OD-OCT IN ENDOSCOPY, 2010-2017

($ MILLIONS) 119

ONCOLOGY 119

Market Revenue 120

TABLE 64 GLOBAL REVENUE OF FF-OCT AND OD-OCT IN ONCOLOGY, THROUGH

2017 ($ MILLIONS) 120

FIGURE 48 GLOBAL REVIEW OF FF-OCT AND OD-OCT IN ONCOLOGY, 2010-2017 ($

MILLIONS) 121

INTERSTITIAL CELL STUDIES 121

Market Revenue 122

TABLE 65 GLOBAL EXPENDITURE OF FF-OCT AND OD-OCT IN INTERSTITIAL CELL

STUDIES, THROUGH 2017 ($ MILLIONS) 122

FIGURE 49 GLOBAL EXPENDITURE OF FF-OCT AND OD-OCT IN INTERSTITIAL CELL

STUDIES, 2010-2017 ($ MILLIONS) 123

OTHERS 123

Market Revenue 124

TABLE 66 GLOBAL EXPENDITURE OF FF-OCT AND OD-OCT IN OTHER CATEGORIES,

THROUGH 2017 ($ MILLIONS) 124

FIGURE 50 GLOBAL EXPENDITURE OF FF-OCT AND OD-OCT IN OTHER CATEGORIES,

2010-2017 ($ MILLIONS) 125

MARKET SHARE 125

TABLE 67 MARKET SHARE OF FF-OCT AND OD-OCT BY END USERS, 2011 (%) 125

FIGURE 51 MARKET SHARE OF FF-OCT AND OD-OCT BY END USERS, 2011 (%) 125

INDUSTRY STRUCTURE 126

FULL-FIELD OPTICAL COHERENCE TOMOGRAPHY 126

Market Leaders 126

TABLE 68 MAJOR MANUFACTURERS IN FF-OCT, 2011 126

Market Share 126

TABLE 69 MARKET SHARE FOR MANUFACTURERS IN FF-OCT, 2011 (%) 127

FIGURE 52 MARKET SHARE FOR MANUFACTURERS IN FF-OCT, 2011 (%) 127

OPTICAL DELAY OPTICAL COHERENCE TOMOGRAPHY 127

Market Leaders 127

TABLE 70 MAJOR MANUFACTURERS IN OD-OCT, 2011 128

Market Share 128

TABLE 71 MARKET SHARE FOR MANUFACTURERS IN OD-OCT, 2011 (%) 128

FIGURE 53 MARKET SHARE FOR MANUFACTURERS IN OD-OCT, 2011 (%) 128

 

CHAPTER 10 PATENT ANALYSIS 130

 

PATENTS BY YEAR 130

TABLE 72 NUMBER OF U.S. PATENTS BY YEAR, FROM 2008 TO 2012 130

FIGURE 54 NUMBER OF U.S. PATENTS BY YEAR, FROM 2008 TO 2012 131

PATENTS BY TYPE 131

TABLE 73 NUMBER OF U.S. PATENTS BY TYPE, FROM 2008-2012 131

FIGURE 55 NUMBER OF U.S. PATENTS BY TYPE, FROM 2008–2012 131

PATENTS BY COMPANY 132

TABLE 74 NUMBER OF U.S. PATENTS BY COMPANY, FROM 2008–OCTOBER 2012 133

PATENTS BY COUNTRY 134

TABLE 75 NUMBER OF U.S. PATENTS BY COUNTRY, FROM 2008-2012 134

PATENTS BY ASSIGNEE 134

TABLE 76 NUMBER OF U.S. PATENTS BY ASSIGNEE, FROM 2008-2012 135

FIGURE 56 NUMBER OF U.S. PATENTS BY ASSIGNEE, FROM 2008–2012 135

 

CHAPTER 11 CURRENT SITUATION 137

 

CHAPTER 12 COMPANY PROFILES 141

 

AGFA HEALTHCARE 141

AGILTRON INCORPORATED 141

BAYSPEC, INC. 141

BIOPTIGEN 142

CARL ZEISS MEDITEC 142

HEIDELBERG ENGINEERING 143

HELIOTIS AG 144

IMALUX CORPORATION 144

LIGHTLAB IMAGING 145

MICHELSON DIAGNOSTICS 145

NIDEK CO., LTD. 146

NOVACAM TECHNOLOGIES INC. 146

NINE POINT MEDICAL 147

OPTOS 147

OPTOVUE, INC. 148

OPTOPOL TECHNOLOGY S.A. 149

PHOENIX RESEARCH LABORATORIES, INC. 149

P&P OPTICA 149

SANTEC CORPORATION 150

SHENZHEN MOPTIM IMAGING TECHNIQUE CO. 150

TOMEY 151

TOMOPHASE CORPORATION 151

TOPCON MEDICAL SYSTEMS, INC. 152

TORNADO SPECTRAL SYSTEMS 152

THORLABS INC. 153

 

CHAPTER 13 APPENDIX I-ABBREVIATIONS 155

 

 

 

LIST OF TABLES

 

SUMMARY TABLE GLOBAL REVENUE OF OCT MARKET, THROUGH 2017 ($ MILLIONS) 8

TABLE 1 MAIN CHARACTERISTICS OF OCT 10

TABLE 2 USES OF OPTICAL COHERENCE TOMOGRAPHY 11

TABLE 3 ADVANTAGES AND DISADVANTAGES OF OPTICAL COHERENCE

TOMOGRAPHY 12

TABLE 4 APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY 13

TABLE 5 HISTORICAL DEVELOPMENTS IN OPTICAL COHERENCE TOMOGRAPHY 14

TABLE 6 TYPE OF TECHNOLOGIES USED IN OPTICAL COHERENCE TOMOGRAPHY 15

TABLE 7 MODES OF IMPLEMENTATION IN OPTICAL COHERENCE TOMOGRAPHY 15

TABLE 8 COMPARISON OF DIFFERENT OCT TECHNOLOGY 19

TABLE 9 NEW OCT PRODUCTS APPROVED FROM 2008 TO 2012 24

TABLE 10 RECALLS AND SAFETY ALERTS FROM 2008 TO 2012 28

TABLE 11 NEW OCT INNOVATIONS FROM 2008 TO 2012 33

TABLE 12 PIPELINE PRODUCTS FOR THE OCT MARKET 36

TABLE 13 GLOBAL REVENUE OF OCT BY TYPE, THROUGH 2017 ($ MILLIONS) 41

TABLE 14 MARKET SHARES OF OCT BY TYPE, 2011 (%) 42

TABLE 15 GLOBAL REVENUE OF OCT BY REGION, THROUGH 2017 ($ MILLIONS) 45

TABLE 16 GLOBAL MARKET SHARE OF OCT BY REGION, 2011 (%) 46

TABLE 17 GLOBAL REVENUE OF TD-OCT AND PS-OCT BY REGION, THROUGH 2017 ($

MILLIONS) 47

TABLE 18 MARKET SHARE OF GLOBAL REVENUE OF TD-OCT AND PS-OCT BY REGION,

2011 (%) 48

TABLE 19 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT BY REGION,

THROUGH 2017 ($ MILLIONS) 49

TABLE 20 MARKET SHARE OF FD-OCT AND TIME-ENCODED OCT BY REGION, 2011

(%) 50

TABLE 21 GLOBAL REVENUE OF FF-OCT AND OD-OCT BY REGION, THROUGH 2017 ($

MILLIONS) 51

TABLE 22 MARKET SHARE OF FF-OCT AND OD-OCT BY REGION, 2011 (%) 52

TABLE 23 GLOBAL MARKET OF OCT BY END USERS, THROUGH 2017 ($ MILLIONS) 60

TABLE 24 GLOBAL MARKET SHARE OF OCT BY END USERS, 2011 (%) 61

TABLE 25 GLOBAL REVENUE OF TD-OCT AND PS-OCT, THROUGH 2017 ($ MILLIONS) 64

TABLE 26 MARKET SHARE OF TD-OCT AND PS-OCT BY TYPE, 2011 (%) 65

TABLE 27 GLOBAL REVENUE OF TD-OCT BY REGION, THROUGH 2017 ($ MILLIONS) 68

TABLE 28 GLOBAL REVENUE OF PS-OCT BY REGION, THROUGH 2017 ($ MILLIONS) 68

TABLE 29 MARKET SHARE OF PS-OCT BY REGION, 2011 (%) 70

TABLE 30 GLOBAL REVENUE OF PS-OCT AND TD-OCT BY END USERS, THROUGH

2017 ($ MILLIONS) 70

TABLE 31 GLOBAL EXPENDITURE OF TD-OCT AND PS-OCT IN THE PHARMACEUTICAL

AND BIOTECHNOLOGY INDUSTRIES, THROUGH 2017 ($ MILLIONS) 73

TABLE 32 GLOBAL EXPENDITURE OF TD-OCT AND PS-OCT IN THE ENVIRONMENTAL

SCIENCES INDUSTRY, THROUGH 2017 ($ MILLIONS) 75

TABLE 33 GLOBAL EXPENDITURE OF TD-OCT AND PS-OCT IN THE FOOD AND

BEVERAGE INDUSTRY, THROUGH 2017 ($ MILLIONS) 76

TABLE 34 GLOBAL EXPENDITURE OF TD-OCT AND PS-OCT IN OTHER INDUSTRIES,

THROUGH 2017 ($ MILLIONS) 78

TABLE 35 MARKET SHARE OF TD-OCT AND PS-OCT BY APPLICATION, 2011 (%) 79

TABLE 36 MAJOR MANUFACTURERS IN TD-OCT, 2011 80

TABLE 37 MARKET SHARE FOR MANUFACTURERS IN TD-OCT, 2011 (%) 80

TABLE 38 MAJOR MANUFACTURERS IN PS-OCT, 2011 81

TABLE 39 MARKET SHARE FOR THE MANUFACTURERS IN PS-OCT, 2011 (%) 81

TABLE 40 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT BY TYPE,

THROUGH 2017 ($ MILLIONS) 86

TABLE 41 MARKET SHARE OF FD-OCT AND TIME-ENCODED OCT, 2011 (%) 87

TABLE 42 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT BY REGION,

THROUGH 2017 ($ MILLIONS) 89

TABLE 43 GLOBAL REVENUE OF FD-OCT BY REGION, THROUGH 2017 ($ MILLIONS) 90

TABLE 44 GLOBAL REVENUE OF TIME-ENCODED OCT BY REGION, THROUGH 2017 ($

MILLIONS) 91

TABLE 45 MARKET SHARES OF FD-OCT AND TIME-ENCODED OCT BY REGION, 2011

(%) 92

TABLE 46 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT BY END USERS,

THROUGH 2017 ($ MILLIONS) 93

TABLE 47 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED DOMAIN OCT IN

CARDIOLOGY, THROUGH 2017 ($ MILLIONS) 95

TABLE 48 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT IN

OPHTHALMOLOGY, THROUGH 2017 ($ MILLIONS) 97

TABLE 49 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT IN ONCOLOGY,

THROUGH 2017 ($ MILLIONS) 98

TABLE 50 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT IN OTHER

SECTORS, THROUGH 2017 ($ MILLIONS) 100

TABLE 51 MARKET SHARE OF FD-OCT AND TIME-ENCODED OCT, 2011 (%) 101

TABLE 52 MAJOR MANUFACTURERS IN FOURIER OR SPECTRAL DOMAIN OCT, 2011 102

TABLE 53 MARKET SHARE OF THE MANUFACTURERS IN FOURIER OR SPECTRAL

DOMAIN OCT, 2011 (%) 103

TABLE 54 MAJOR MANUFACTURERS IN TIME-ENCODED OCT OR SS-OCT, 2011 104

TABLE 55 MARKET SHARE OF THE MANUFACTURERS OF TIME-ENCODED OCT OR

SS-OCT, 2011 (%) 104

TABLE 56 GLOBAL REVENUE OF FF-OCT AND OD-OCT, THROUGH 2017 ($ MILLIONS) 109

TABLE 57 MARKET SHARE OF FF-OCT AND OD-OCT BY TYPE, 2011 (%) 110

TABLE 58 GLOBAL REVENUE OF FF-OCT AND OD-OCT BY REGION, THROUGH 2017 ($

MILLIONS) 112

TABLE 59 GLOBAL REVENUE OF FF-OCT BY REGION, THROUGH 2017 ($ MILLIONS) 113

TABLE 60 GLOBAL REVENUE OF OD-OCT BY REGION, THROUGH 2017 ($ MILLIONS) 114

TABLE 61 MARKET SHARE OF FF-OCT AND OD-OCT BY REGION, 2011 (%) 115

TABLE 62 GLOBAL REVENUE OF FF-OCT AND OD-OCT BY END USERS, THROUGH

2017 ($ MILLIONS) 117

TABLE 63 GLOBAL REVENUE OF FF-OCT AND OD-OCT IN ENDOSCOPY, THROUGH

2017 ($ MILLIONS) 119

TABLE 64 GLOBAL REVENUE OF FF-OCT AND OD-OCT IN ONCOLOGY, THROUGH

2017 ($ MILLIONS) 120

TABLE 65 GLOBAL EXPENDITURE OF FF-OCT AND OD-OCT IN INTERSTITIAL CELL

STUDIES, THROUGH 2017 ($ MILLIONS) 122

TABLE 66 GLOBAL EXPENDITURE OF FF-OCT AND OD-OCT IN OTHER CATEGORIES,

THROUGH 2017 ($ MILLIONS) 124

TABLE 67 MARKET SHARE OF FF-OCT AND OD-OCT BY END USERS, 2011 (%) 125

TABLE 68 MAJOR MANUFACTURERS IN FF-OCT, 2011 126

TABLE 69 MARKET SHARE FOR MANUFACTURERS IN FF-OCT, 2011 (%) 127

TABLE 70 MAJOR MANUFACTURERS IN OD-OCT, 2011 128

TABLE 71 MARKET SHARE FOR MANUFACTURERS IN OD-OCT, 2011 (%) 128

TABLE 72 NUMBER OF U.S. PATENTS BY YEAR, FROM 2008 TO 2012 130

TABLE 73 NUMBER OF U.S. PATENTS BY TYPE, FROM 2008-2012 131

TABLE 74 NUMBER OF U.S. PATENTS BY COMPANY, FROM 2008–OCTOBER 2012 133

TABLE 75 NUMBER OF U.S. PATENTS BY COUNTRY, FROM 2008-2012 134

TABLE 76 NUMBER OF U.S. PATENTS BY ASSIGNEE, FROM 2008-2012 135

 

 

 

LIST OF FIGURES

 

SUMMARY FIGURE GLOBAL REVENUE OF OCT MARKET, 2010-2017 ($ MILLIONS) 8

FIGURE 1 GLOBAL REVENUE OF OCT BY TYPE, 2010-2017 ($ MILLIONS) 41

FIGURE 2 MARKET SHARES OF OCT BY TYPE, 2011 (%) 42

FIGURE 3 GLOBAL REVENUE OF OCT BY REGION, 2010-2017 ($ MILLIONS) 45

FIGURE 4 GLOBAL MARKET SHARE OF OCT BY REGION, 2011 (%) 46

FIGURE 5 GLOBAL REVENUE OF TD-OCT AND PS-OCT BY REGION, 2010-2017 ($

MILLIONS) 47

FIGURE 6 MARKET SHARE OF GLOBAL REVENUE OF TD-OCT AND PS-OCT BY REGION,

2011 (%) 48

FIGURE 7 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT BY REGION,

2010-2017 ($ MILLIONS) 49

FIGURE 8 MARKET SHARE OF FD-OCT AND TIME-ENCODED OCT BY REGION, 2011 (%) 50

FIGURE 9 GLOBAL REVENUE OF FF-OCT AND OD-OCT BY REGION, 2010-2017 ($

MILLIONS) 51

FIGURE 10 MARKET SHARE OF FF-OCT AND OD-OCT BY REGION, 2011 (%) 52

FIGURE 11 GLOBAL MARKET OF OCT BY END USERS, 2010-2017 ($ MILLIONS) 60

FIGURE 12 GLOBAL MARKET SHARE OF OCT BY END USERS, 2011 (%) 61

FIGURE 13 GLOBAL REVENUE OF TD-OCT AND PS-OCT, 2010-2017 ($ MILLIONS) 64

FIGURE 14 MARKET SHARE OF TD-OCT AND PS-OCT BY TYPE, 2011 (%) 65

FIGURE 15 GLOBAL REVENUE OF TD-OCT BY REGION, 2010-2017 ($ MILLIONS) 68

FIGURE 16 GLOBAL REVENUE OF PS-OCT BY REGION, 2010-2017 ($ MILLIONS) 69

FIGURE 17 MARKET SHARE OF PS-OCT BY REGION, 2011 (%) 70

FIGURE 18 GLOBAL REVENUE OF PS-OCT AND TD-OCT BY END USERS, 2010-2017 ($

MILLIONS) 72

FIGURE 19 GLOBAL EXPENDITURE OF TD-OCT AND PS-OCT IN THE

PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES, 2010-2017 ($ MILLIONS) 73

FIGURE 20 GLOBAL EXPENDITURE OF TD-OCT AND PS-OCT IN THE ENVIRONMENTAL

SCIENCES INDUSTRY, 2010-2017 ($ MILLIONS) 75

FIGURE 21 GLOBAL EXPENDITURE OF TD-OCT AND PS-OCT IN THE FOOD AND

BEVERAGE INDUSTRY, 2010-2017 ($ MILLIONS) 77

FIGURE 22 GLOBAL EXPENDITURE OF TD-OCT AND PS-OCT IN OTHER INDUSTRIES,

2010-2017 ($ MILLIONS) 78

FIGURE 23 MARKET SHARE OF TD-OCT AND PS-OCT BY APPLICATION, 2011 (%) 79

FIGURE 24 MARKET SHARE FOR MANUFACTURERS IN TD-OCT, 2011 (%) 80

FIGURE 25 MARKET SHARE FOR THE MANUFACTURERS IN PS-OCT, 2011 (%) 81

FIGURE 26 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT BY TYPE,

2010-2017 ($ MILLIONS) 86

FIGURE 27 MARKET SHARE OF FD-OCT AND TIME-ENCODED OCT, 2011 (%) 87

FIGURE 28 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT BY REGION,

2010-2017 ($ MILLIONS) 89

FIGURE 29 GLOBAL REVENUE OF FD-OCT BY REGION, 2010-2017 ($ MILLIONS) 90

FIGURE 30 GLOBAL REVENUE OF TIME-ENCODED OCT BY REGION, 2010-2017 ($

MILLIONS) 91

FIGURE 31 MARKET SHARES OF FD-OCT AND TIME-ENCODED OCT BY REGION, 2011

(%) 92

FIGURE 32 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT BY END USERS,

2010-2017 ($ MILLIONS) 93

FIGURE 33 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED DOMAIN OCT IN

CARDIOLOGY, 2010-2017 ($ MILLIONS) 95

FIGURE 34 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT IN

OPHTHALMOLOGY, 2010-2017 ($ MILLIONS) 97

FIGURE 35 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT IN ONCOLOGY,

2010-2017 ($ MILLIONS) 99

FIGURE 36 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT IN OTHER

SECTORS, 2010-2017 ($ MILLIONS) 101

FIGURE 37 MARKET SHARE OF FD-OCT AND TIME-ENCODED OCT, 2011 (%) 101

FIGURE 38 MARKET SHARE OF THE MANUFACTURERS IN FOURIER OR SPECTRAL

DOMAIN OCT, 2011 (%) 103

FIGURE 39 MARKET SHARE OF THE MANUFACTURERS OF TIME-ENCODED OCT OR

SS-OCT, 2011 (%) 104

FIGURE 40 GLOBAL REVENUE OF FF-OCT AND OD-OCT, 2010–2017 ($ MILLIONS) 109

FIGURE 41 MARKET SHARE OF FF-OCT AND OD-OCT BY TYPE, 2011 (%) 110

FIGURE 42 GLOBAL REVENUE OF FF-OCT AND OD-OCT BY REGION, 2010-2017 ($

MILLIONS) 113

FIGURE 43 GLOBAL REVENUE OF FF-OCT BY REGION, THROUGH 2017 ($ MILLIONS) 114

FIGURE 44 GLOBAL REVENUE OF OD-OCT BY REGION, 2010-2017 ($ MILLIONS) 114

FIGURE 45 MARKET SHARE OF FF-OCT AND OD-OCT BY REGION, 2011 (%) 115

FIGURE 46 GLOBAL REVENUE OF FF-OCT AND OD-OCT BY END USERS, 2010-2017 ($

MILLIONS) 117

FIGURE 47 GLOBAL REVENUE OF FF-OCT AND OD-OCT IN ENDOSCOPY, 2010-2017

($ MILLIONS) 119

FIGURE 48 GLOBAL REVIEW OF FF-OCT AND OD-OCT IN ONCOLOGY, 2010-2017 ($

MILLIONS) 121

FIGURE 49 GLOBAL EXPENDITURE OF FF-OCT AND OD-OCT IN INTERSTITIAL CELL

STUDIES, 2010-2017 ($ MILLIONS) 123

FIGURE 50 GLOBAL EXPENDITURE OF FF-OCT AND OD-OCT IN OTHER CATEGORIES,

2010-2017 ($ MILLIONS) 125

FIGURE 51 MARKET SHARE OF FF-OCT AND OD-OCT BY END USERS, 2011 (%) 125

FIGURE 52 MARKET SHARE FOR MANUFACTURERS IN FF-OCT, 2011 (%) 127

FIGURE 53 MARKET SHARE FOR MANUFACTURERS IN OD-OCT, 2011 (%) 128

FIGURE 54 NUMBER OF U.S. PATENTS BY YEAR, FROM 2008 TO 2012 131

FIGURE 55 NUMBER OF U.S. PATENTS BY TYPE, FROM 2008–2012 131

FIGURE 56 NUMBER OF U.S. PATENTS BY ASSIGNEE, FROM 2008–2012 135

 

 

 

To order this report:

Medical_Imaging Industry: Global Markets and Technologies for Optical Coherence Tomography (OCT)

 

Contact Clare: clare@reportlinker.com
US:(339) 368 6001
Intl:+1 339 368 6001

 


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved


Related medicine technology :

1. Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
2. TRACE Releases 2012 Global Enforcement Report
3. Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
4. PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems
5. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City
6. HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast
7. Amgen To Present At The UBS Global Life Sciences Conference
8. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
9. The Rockley Group and Content Rules Ink Deal to Extend Global Reach
10. Cumberland Pharmaceuticals To Present At The UBS Global Healthcare Conference In New York
11. Global Information Online Market Research Portal Provides Complimentary Sample Service for Customers to Preview Reports by Global Industry Analysts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... de fevereiro de 2016  A Proliant Biologicals ... de soroalbumina bovina (BSA -- Bovine Serum ... na Ilha Norte da Nova Zelândia, em Feilding. ... na fábrica da Proliant nos EUA, localizada em ... e instalação dos equipamentos foram feitos de forma ...
(Date:2/11/2016)... Transformational M&A achieved through NPS and Dyax acquisitions and the ... achieved through NPS and Dyax acquisitions and the announced combination ... through NPS and Dyax acquisitions and the announced combination with ... robust pipeline in Shire , s history   ... pipeline in Shire , s history   ...
(Date:2/11/2016)... 2016 Breast Cancer Therapeutics in Asia-Pacific ... Asia-Pacific (APAC) breast cancer market will experience considerable ... 2021, at a Compound Annual Growth Rate (CAGR) of 8.5%. ... 2021 - states that the Asia-Pacific ... $1.9 billion in 2014 to $3.4 billion by 2021, at ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... 11, 2016 , ... Florida Hospital presents Heart Health Awareness night on Sunday ... at the Amalie Arena. The puck drops at 6:00pm, but fans will have the ... prior to the game. The MEGA Heart will be located on Ford Thunder Alley ...
(Date:2/11/2016)... ... February 11, 2016 , ... The Chartis ... the top five firms in the “2015/2016 Best in KLAS: Software and Services” ... KLAS is a research and insights firm on a global mission to improve ...
(Date:2/11/2016)... ... February 11, 2016 , ... In ... Dallas plastic surgeon , Dr. Rod J. Rohrich, and colleagues, examine and ... Rohrich outlines recommendations for rhinoplasty surgeons when addressing this vital area. , The ...
(Date:2/11/2016)... ... February 11, 2016 , ... "What holds you back ... Clarke poses a question as a challenge for his readers to examine the ... the Being" (published by Partridge Singapore), Clarke explores the subject with more depth, ...
(Date:2/11/2016)... ... February 11, 2016 , ... Colorado spine surgeon, Donald Corenman, MD, DC ... surgeons to know in 2016 . The list consists of spine surgeons across the ... , Dr. Corenman understands the importance of clinical excellence; he has been awarded the ...
Breaking Medicine News(10 mins):